Literature DB >> 21622177

Protein-ligand docking.

Giovanni Bottegoni1.   

Abstract

Ligand-docking is an established computational technique universally applied in structure-based drug design. Since the first attempts carried out in the early '80s to predict the three-dimensional conformation of a protein-ligand bound complex, this methodology has evolved constantly and it is presently implemented in many different ways. The present study aims at explaining the standard protein-ligand docking protocol, together with its main advantages and drawbacks. Milestone reports and future directions are reported and discussed as well.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21622177     DOI: 10.2741/3854

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  7 in total

1.  28-Homobrassinolide: a novel oxysterol transactivating LXR gene expression.

Authors:  R Premalatha; K Srikumar; D Vijayalaksmi; G N Kumar; P P Mathur
Journal:  Mol Biol Rep       Date:  2014-08-05       Impact factor: 2.316

2.  Retrospective molecular docking study of WY-25105 ligand to β-secretase and bias of the three-dimensional structure flexibility.

Authors:  Leo Ghemtio; Nicolas Muzet
Journal:  J Mol Model       Date:  2013-04-07       Impact factor: 1.810

Review 3.  Protein flexibility in docking and surface mapping.

Authors:  Katrina W Lexa; Heather A Carlson
Journal:  Q Rev Biophys       Date:  2012-05-09       Impact factor: 5.318

4.  LigandRNA: computational predictor of RNA-ligand interactions.

Authors:  Anna Philips; Kaja Milanowska; Grzegorz Lach; Janusz M Bujnicki
Journal:  RNA       Date:  2013-10-21       Impact factor: 4.942

Review 5.  Dynamic Docking: A Paradigm Shift in Computational Drug Discovery.

Authors:  Dario Gioia; Martina Bertazzo; Maurizio Recanatini; Matteo Masetti; Andrea Cavalli
Journal:  Molecules       Date:  2017-11-22       Impact factor: 4.411

6.  Design of a Structurally Novel Multipotent Drug Candidate by the Scaffold Architecture Technique for ACE-II, NSP15, and Mpro Protein Inhibition: Identification and Isolation of a Natural Product to Prevent the Severity of Future Variants of Covid 19 and a Colorectal Anticancer Drug.

Authors:  Sourav Pakrashy; Prakash K Mandal; Surya Kanta Dey; Sujata Maiti Choudhury; Fatmah Ali Alasmary; Amani Salem Almalki; Md Ataul Islam; Malay Dolai
Journal:  ACS Omega       Date:  2022-09-10

7.  A molecular-modeling toolbox aimed at bridging the gap between medicinal chemistry and computational sciences.

Authors:  Sameh Eid; Adam Zalewski; Martin Smieško; Beat Ernst; Angelo Vedani
Journal:  Int J Mol Sci       Date:  2013-01-04       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.